Antibiotice Iași – Investments worth 75 million euros for the development of a research, development and production center for critical medicines, through the STEP program
Antibiotice S.A. signed, together with the Ministry of Investments and European Projects (MIPE), a financing contract worth 75 million euros for the implementation of the project “INOVA a+ Center for Research, Development and Production of Critical Medicines”, financed through the Health Program – Priority 9 (STEP).
The project will support the Romanian healthcare system by creating a modern production infrastructure for critical medicines, while also contributing to the European Union’s strategic autonomy in the pharmaceutical field by securing supply chains and by increasing the resilience of European healthcare systems.
Out of the total eligible value of the project, 52% represents non-reimbursable financing provided by the MIPE and the rest is provided by Antibiotice. The project implementation is scheduled for the period November 2025 – November 2029.
“This large investment project is a decisive step towards the future for Antibiotice, a strategic initiative that will integrate resources, expertise and collaborations between the industry and the research environment, strengthening our company’s position as a strategic manufacturer of critical medicines at national and European levels. Also, the project brings along a complex challenge, which we will address through solid partnerships and the rigorous management of financial and profitability balances. The fact that we are launching this project in the year when we celebrate our company’s 70th anniversary is proof of our constant commitment to innovation and development for the benefit of the health of the Romanian population and with a significant impact at a global level”, Ioan Nani, General Director of Antibiotice stated.
The signing of the contract took place during the 7th meeting of the Monitoring Committee for the Health Program, organized by the MIPE and hosted by Antibiotice Iași between November 11–12, 2025. The event was attended by Mr. Dragoș-Nicolae Pîslaru, the Minister of Investments and European Projects, Mr. Alexandru Rogobete, the Minister of Health, representatives of the European Commission, the MIPE, as well as by members of the Monitoring Committee for the Health Program
You can read more here
